Glycosidase inhibitors and uses thereof

The invention provides compounds with enhanced permeability for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to defi...

Full description

Saved in:
Bibliographic Details
Main Authors Kaul Ramesh, Liu Kun, Chang Jiang, Selnick Harold G, Wei Zhongyong, Wang Yaode, McEachern Ernest J
Format Patent
LanguageEnglish
Published 10.04.2018
Subjects
ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR
CHEMISTRY
CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS,e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES,DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS
CONVEYING
HANDLING THIN OR FILAMENTARY MATERIAL
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
PACKAGES
PACKAGING ELEMENTS
PACKING
PERFORMING OPERATIONS
STORING
TRANSPORTING
Online AccessGet full text

Cover

Abstract The invention provides compounds with enhanced permeability for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
AbstractList The invention provides compounds with enhanced permeability for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
Author Chang Jiang
McEachern Ernest J
Kaul Ramesh
Selnick Harold G
Liu Kun
Wei Zhongyong
Wang Yaode
Author_xml – fullname: Kaul Ramesh
– fullname: Liu Kun
– fullname: Chang Jiang
– fullname: Selnick Harold G
– fullname: Wei Zhongyong
– fullname: Wang Yaode
– fullname: McEachern Ernest J
BookMark eNrjYmDJy89L5WRQd8-pTM4vzkxJLE5VyMzLyEzKLMkvKlZIzEtRKC1OLVYoyUgtSs1P42FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8aHBlpbGFkaWlk5GxkQoAQBZVSnS
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US9938299B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US9938299B23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:58:10 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US9938299B23
Notes Application Number: US201314655222
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180410&DB=EPODOC&CC=US&NR=9938299B2
ParticipantIDs epo_espacenet_US9938299B2
PublicationCentury 2000
PublicationDate 20180410
PublicationDateYYYYMMDD 2018-04-10
PublicationDate_xml – month: 04
  year: 2018
  text: 20180410
  day: 10
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies ALECTOS THERAPEUTICS, INC
MERCK SHARP & DOHME CORP
RelatedCompanies_xml – name: ALECTOS THERAPEUTICS, INC
– name: MERCK SHARP & DOHME CORP
Score 3.1354475
Snippet The invention provides compounds with enhanced permeability for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR
CHEMISTRY
CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS,e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES,DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS
CONVEYING
HANDLING THIN OR FILAMENTARY MATERIAL
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
PACKAGES
PACKAGING ELEMENTS
PACKING
PERFORMING OPERATIONS
STORING
TRANSPORTING
Title Glycosidase inhibitors and uses thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180410&DB=EPODOC&locale=&CC=US&NR=9938299B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig9Sn4r9SNvtoQhtV4ewD9wqextNk2JBumE7xP_eS-imL_oWEsjHkbvf_ZLcBeDOYujnZgbVPeYgQUm5rfdcIXTm5dzgppXZVAY4j8buMKHPC2fRgmIbC6PyhH6q5IioURnqe63s9frnECtSbyurB1Zg1eoxnvuR1rBjU2bTMbQo8AfTSTQJtTD0k5k2fvERhntoeQO01nvoRXuKs70GMihl_RtR4mPYn2JnZX0CLVF24DDcfrzWgYNRc9-NxUb1qlO4f3r_yla4dxB2SFG-FayQH-WQtORkU4mKSE9OrPIzIPFgHg51HHG5W90yme3mZp9DG0m_uABi5akp0JXLLDulfeRQlKfUQUDvu4zm3O5C989uLv9pu4IjKSZ5H2Ia19CuPzbiBmG1ZrdKIN8PKnxz
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsX52QepT8V-pFv3UIS2q1XXbbhO9jaaJsWCdMN2iP-9l9JNX_QtJJCPI3e_-yW5C8CNTtHPTVSi9KiJBCVmhmJ1OVdoL2Uq0_TEICLAORx1gxl5mpvzBmSbWJgqT-hnlRwRNSpBfS8re736OcTyqreVxR3NsGp570e2J9fsWBPZdFTZc-zBZOyNXdl17dlUHr3YCMMWWl4HrfUOethWxZReHRGUsvqNKP4B7E6ws7w8hAbP29ByNx-vtWEvrO-7sVirXnEEtw_vX8kS9w7CjpTlbxnNxEc5UpwzaV3wQhKeHF-mxyD5g8gNFBxxsV3dYjbdzs04gSaSfn4Kkp7GGkdXLtGNmPSRQxEWExMBvd-lJGVGBzp_dnP2T9s1tIIoHC6Gj6Pnc9gXIhN3I5p6Ac3yY80vEWJLelUJ5xsMpH9j
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Glycosidase+inhibitors+and+uses+thereof&rft.inventor=Kaul+Ramesh&rft.inventor=Liu+Kun&rft.inventor=Chang+Jiang&rft.inventor=Selnick+Harold+G&rft.inventor=Wei+Zhongyong&rft.inventor=Wang+Yaode&rft.inventor=McEachern+Ernest+J&rft.date=2018-04-10&rft.externalDBID=B2&rft.externalDocID=US9938299B2